453 results
Page 13 of 23
8-K
3fng fuhblou
10 Aug 12
Completion of Acquisition or Disposition of Assets
12:00am
424B5
da8ahhk xtighugp49
27 Jul 12
Prospectus supplement for primary offering
12:00am
424B3
2uahp2jgd kpxhhlm7s
26 Jul 12
Prospectus supplement
12:00am
8-K
EX-99.1
0q55dc
25 Jul 12
Planned Acquisition of Amylin Expected to Add Two Marketed GLP-1 Agonists to Our Diabetes Franchise and Our Alliance with AstraZeneca
12:00am
SC TO-T/A
EX-99
dfoob7fyxeu7 hk
23 Jul 12
Third party tender offer statement (amended)
12:00am
SC TO-T/A
qxtj1uz7uh
23 Jul 12
Third party tender offer statement (amended)
12:00am
SC TO-T/A
EX-99
i51kugwatab4ehs a4
23 Jul 12
Third party tender offer statement (amended)
12:00am
8-K
EX-2.1
qmdd 40kpa
3 Jul 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
nl75bpqe
3 Jul 12
Entry into a Material Definitive Agreement
12:00am
CORRESP
70z2 dflrvy
17 May 12
Correspondence with SEC
12:00am
8-K
EX-99.1
oeh s8eut
26 Apr 12
Bristol-Myers Squibb Delivers a Solid First Quarter with Strong Operating Results and Key R&D Milestones
12:00am
SC TO-T/A
ze59xp2r
13 Feb 12
Third party tender offer statement (amended)
12:00am
8-K
3u7abro 2vsyezgwigp
13 Feb 12
Other Events
12:00am
8-K
EX-99.1
d3tc0g043zs ic6h0
26 Jan 12
Net Sales Rise 7% to $5.5 Billion in Fourth Quarter
12:00am
SC TO-T/A
gl89xm8sp
19 Jan 12
Third party tender offer statement (amended)
12:00am